Panel: Biotech CEO Insights: Strategies for Innovation, Resilience & the Road Ahead

Session details:

Biotech is undergoing a profound transformation. After a period of capital tightening, workforce reductions, and shifting investor expectations, today’s CEOs are tasked with not only stabilizing their companies—but also reigniting innovation in a more demanding, data-driven world. This headline session brings together top biotech leaders to discuss how they’re adapting business models, doubling down on platform science, navigating regulatory complexity, and future-proofing their organizations for sustainable growth. It’s a candid look at leadership in Biotech 2.0 from bold risk-taking to long-term discipline.

• Innovation with Intent: Identifying the right scientific bets and integrating AI, platform tech, and translational strategy
• Strategic Resilience: Operating leaner, prioritizing assets, and managing investor pressure without compromising vision
• The New Capital Game: How CEOs are navigating capital markets, non-dilutive funding, and deal-making in 2025
• Leading Impact: Building high-performing teams and cultures that attract talent and drive lasting patient value.